These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 4819260)

  • 1. Letter: Heparin, aspirin and Lee-White clotting time.
    Gurewich V
    Chest; 1974 Apr; 65(4):475. PubMed ID: 4819260
    [No Abstract]   [Full Text] [Related]  

  • 2. Letter: Heparin, aspirin and Lee-White clotting time.
    Kwaan HC
    Chest; 1974 Apr; 65(4):475-6. PubMed ID: 4819261
    [No Abstract]   [Full Text] [Related]  

  • 3. Letter: Heparin, aspirin and Lee-White clotting time.
    McIntyre KE
    Chest; 1974 Apr; 65(4):475. PubMed ID: 4819259
    [No Abstract]   [Full Text] [Related]  

  • 4. Influence of simultaneous administration of low-dose heparin and acetylsalicylic acid on blood coagulation and platelet functions.
    Loew D; Vinazzer H
    Haemostasis; 1974; 3(5-6):319-28. PubMed ID: 4468231
    [No Abstract]   [Full Text] [Related]  

  • 5. [Influence of preoperative treatment with aspirin or heparin on platelet function and intensity of postoperative bleeding in early period after coronary artery bypass surgery].
    Veikutiene A; Sirvinskas E; Grybauskas P; Cimbolaityte J; Mongirdiene A; Veikutis V
    Medicina (Kaunas); 2005; 41(7):577-83. PubMed ID: 16062025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathogenesis of epizootic hemorrhagic disease. I. Blood coagulation during viral infection.
    Debbie JG; Abelseth MK
    J Infect Dis; 1971 Aug; 124(2):217-22. PubMed ID: 5124972
    [No Abstract]   [Full Text] [Related]  

  • 7. The mechanisms of venous thrombosis. Anticoagulants, aspirin, and heparin.
    O'Brien JR
    Mod Concepts Cardiovasc Dis; 1973 Mar; 42(3):11-5. PubMed ID: 4572065
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effect of heparin, acetylsalicylic acid and sulfinpyrazone on thrombocyte morphology].
    Fritsche HM; Ketterl R; Leimgruber D; Blümel G
    Med Welt; 1979 Mar; 30(10):365-9. PubMed ID: 763120
    [No Abstract]   [Full Text] [Related]  

  • 9. Influence of aspirin or heparin on platelet function and postoperative blood loss after coronary artery bypass surgery.
    Sirvinskas E; Veikutiene A; Grybauskas P; Cimbolaityte J; Mongirdiene A; Veikutis V; Raliene L
    Perfusion; 2006 Jan; 21(1):61-6. PubMed ID: 16485701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clotting, activated partial thromboplastin and coagulation times in monitoring heparin therapy.
    Kurec AS; Morris MW; Davey FR
    Ann Clin Lab Sci; 1979; 9(6):494-500. PubMed ID: 518012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Possible mechanism of the synergistic effect of heparin and dihydroergotamine.
    Kakkar VV; Welzel D; Murray WJ; Malone P; Jones D
    Am J Surg; 1985 Oct; 150(4A):33-8. PubMed ID: 4051120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of venous thromboembolism.
    Kakkar VV
    Clin Haematol; 1981 Jun; 10(2):543-82. PubMed ID: 6172228
    [No Abstract]   [Full Text] [Related]  

  • 13. [Monitoring of antiplatelet drug effects--fashion or necessity?].
    Kuliczkowski W; Zembala M; Poloński L; Kaczmarski J; Gasior M
    Kardiol Pol; 2008 Jan; 66(1):119-24. PubMed ID: 18266199
    [No Abstract]   [Full Text] [Related]  

  • 14. [Anticoagulants and pregnancy].
    Makatsariia AD; Limonova SG
    Akush Ginekol (Mosk); 1981 May; (5):5-8. PubMed ID: 7027813
    [No Abstract]   [Full Text] [Related]  

  • 15. [Heparin anticoagulant activity: new knowledge and future prospects].
    Camici M; Giusti C; Evangelisti L
    Recenti Prog Med; 1991 Apr; 82(4):209-18. PubMed ID: 1857840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship of the partial thromboplastin time to the Lee-White coagulation time.
    MacAulay MA; Frisch CR; Klionsky BL
    Tech Bull Regist Med Technol; 1968 Aug; 38(8):223-7. PubMed ID: 5678598
    [No Abstract]   [Full Text] [Related]  

  • 17. [Measurement of activated whole blood coagulation as a control parameter for heparin dosage in hemodialysis].
    Kraatz G; Lopot F
    Z Urol Nephrol; 1984 Aug; 77(8):465-71. PubMed ID: 6495895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of unfractionated heparin for the antiaggregatory effect of aspirin in patients undergoing carotid endarterectomy: Results of an observational clinical study.
    Brenner T; Schmitt FC; Demirel S; Salgado E; Celi de la Torre JA; Göring M; Bruckner T; Böckler D; Weigand MA; Hofer S; Attigah N
    Vascular; 2017 Feb; 25(1):19-27. PubMed ID: 26993144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rivaroxaban and dabigatran did not affect clotting profiles in plasma reconstituted with varying levels of autologous platelets to the same degree as heparin when evaluated using thromboelastography.
    Gantioqui J; Stevic I; Atkinson H; Chan AKC
    Blood Coagul Fibrinolysis; 2018 Sep; 29(6):521-527. PubMed ID: 29965810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel synthetic inhibitor of factor Xa decreases early reocclusion and improves 24-h patency after coronary fibrinolysis in dogs.
    Abendschein DR; Baum PK; Verhallen P; Eisenberg PR; Sullivan ME; Light DR
    J Pharmacol Exp Ther; 2001 Feb; 296(2):567-72. PubMed ID: 11160645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.